Suppression of the Malignant Phenotype of Bladder Cancer Cells Investigations of the Proteome in Relation to Phenotype and Gene Expression

Similar documents
Network-assisted data analysis

Analysis of Massively Parallel Sequencing Data Application of Illumina Sequencing to the Genetics of Human Cancers

Symposium on Protein Fractionation

New Developments in LC-IMS-MS Proteomic Measurements and Informatic Analyses

Proteomic Biomarker Discovery in Breast Cancer

Gene Ontology and Functional Enrichment. Genome 559: Introduction to Statistical and Computational Genomics Elhanan Borenstein

One Gene, Many Proteins. Applications of Mass Spectrometry to Proteomics. Why Proteomics? Raghothama Chaerkady, Ph.D.

Metabolomics: quantifying the phenotype

RNA-seq Introduction

Complexity DNA. Genome RNA. Transcriptome. Protein. Proteome. Metabolites. Metabolome

The Avatar System TM Yields Biologically Relevant Results

The Analysis of Proteomic Spectra from Serum Samples. Keith Baggerly Biostatistics & Applied Mathematics MD Anderson Cancer Center

Introduction to Proteomics 1.0

Mass Spectrometry and Proteomics - Lecture 4 - Matthias Trost Newcastle University

4th Multidimensional Chromatography Workshop Toronto (January, 2013) Herman C. Lam, Ph.D. Calibration & Validation Group

Glycosylation analysis of blood plasma proteins

MSSimulator. Simulation of Mass Spectrometry Data. Chris Bielow, Stephan Aiche, Sandro Andreotti, Knut Reinert FU Berlin, Germany

W.M. Keck Foundation Biotechnology Resource Laboratories. Erol Gulcicek Christopher Colangelo Terence Wu

MammaPrint, the story of the 70-gene profile

Gene Regulation Part 2

Deploying the full transcriptome using RNA sequencing. Jo Vandesompele, CSO and co-founder The Non-Coding Genome May 12, 2016, Leuven

HepaRG LX2. HepaRG HepaRG LX2 LX2

Digitizing the Proteomes From Big Tissue Biobanks

Experimental Design For Microarray Experiments. Robert Gentleman, Denise Scholtens Arden Miller, Sandrine Dudoit

Germline Genetic Testing for Breast Cancer Risk

Mass Spectrometry and Proteomics. Professor Xudong Yao Bioanalytical Chemistry Spring 2007

High-Throughput Sequencing Course

Proteomics to identify novel biomarkers and therapeutic targets in cardiovascular disease

Proteome analysis Cellular proteomics Plasma proteomics

Unsupervised Identification of Isotope-Labeled Peptides

TITLE: Early Lung Cancer Detection via Global Protein Modification Profiles

Chapter 3. Structure of Enzymes. Enzyme Engineering

Using CART to Mine SELDI ProteinChip Data for Biomarkers and Disease Stratification

Analysis of Peptides via Capillary HPLC and Fraction Collection Directly onto a MALDI Plate for Off-line Analysis by MALDI-TOF

T. R. Golub, D. K. Slonim & Others 1999

RECENT ADVANCES IN THE MOLECULAR DIAGNOSIS OF BREAST CANCER

Chapter 10apter 9. Chapter 10. Summary

Introduction to Cancer Bioinformatics and cancer biology. Anthony Gitter Cancer Bioinformatics (BMI 826/CS 838) January 20, 2015

LECTURE-15. itraq Clinical Applications HANDOUT. Isobaric Tagging for Relative and Absolute quantitation (itraq) is a quantitative MS

micrornas (mirna) and Biomarkers

Mass Spectrometry and Proteomics Xudong Yao

Metabolomic and Proteomics Solutions for Integrated Biology. Christine Miller Omics Market Manager ASMS 2015

MASS SPECTROMETRIC CHARACTERIZATION OF ELASTIN PEPTIDES AND THE EFFECT OF SOLAR RADIATION ON ELASTIN. Dissertation

Page 1 of 5 Biochemistry I Fall 2017 Practice for Exam2 Dr. Stone Name

Proteomics and Rational Drug Design. Dr Gilda Tachedjian Molecular Interactions Group Dec 2006

Section 1 Proteins and Proteomics

Predictive Assays in Radiation Therapy

New Instruments and Services

Simple, rapid, and reliable RNA sequencing

Supplemental Data. Integrating omics and alternative splicing i reveals insights i into grape response to high temperature

MALDI Imaging Mass Spectrometry

Chapter 3. Protein Structure and Function

Title: Human breast cancer associated fibroblasts exhibit subtype specific gene expression profiles

New Instruments and Services

Introduction: 年 Fas signal-mediated apoptosis. PI3K/Akt

David M. Rocke Division of Biostatistics Department of Public Health Sciences University of California, Davis

White Paper Estimating Complex Phenotype Prevalence Using Predictive Models

From single studies to an EBM based assessment some central issues

Hands-On Ten The BRCA1 Gene and Protein

1. Sample Introduction to MS Systems:

MIRROR IMAGE MIRROR IMAGE. The future of cancer diagnostics may be closer than it appears

ANALYTISCHE STRATEGIE Tissue Imaging. Bernd Bodenmiller Institute of Molecular Life Sciences University of Zurich

Practical Reference Dosimetry Course April 2015 PRDC Program, at a glance. Version 1.0. Day 1 Day 2 Day 3 Day 4

Outline. Outline. Phillip G. Febbo, MD. Genomic Approaches to Outcome Prediction in Prostate Cancer

PTM Discovery Method for Automated Identification and Sequencing of Phosphopeptides Using the Q TRAP LC/MS/MS System

Machine Learning! Robert Stengel! Robotics and Intelligent Systems MAE 345,! Princeton University, 2017

Isolation of five carotenoid compounds from tangerine tomatoes

The Detection of Allergens in Food Products with LC-MS

Chemical Biology, Option II Mechanism Based Proteomic Tagging Case History CH1

Biological Mass Spectrometry. April 30, 2014

EPIGENOMICS PROFILING SERVICES

Cellecta Overview. Started Operations in 2007 Headquarters: Mountain View, CA

genomics for systems biology / ISB2020 RNA sequencing (RNA-seq)

MBios 478: Systems Biology and Bayesian Networks, 27 [Dr. Wyrick] Slide #1. Lecture 27: Systems Biology and Bayesian Networks

Analysis of small RNAs from Drosophila Schneider cells using the Small RNA assay on the Agilent 2100 bioanalyzer. Application Note

Aeris. Precision Engineered Core- Shell Particles for Ultra-High Resolution BioSeparations. Aeris PEPTIDE. Aeris WIDEPORE

[ APPLICATION NOTE ] High Sensitivity Intact Monoclonal Antibody (mab) HRMS Quantification APPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS KEYWORDS

SUPPLEMENTARY APPENDIX

Radiomics: a new era for tumour management?

TECHNICAL BULLETIN. R 2 GlcNAcβ1 4GlcNAcβ1 Asn

Paternal exposure and effects on microrna and mrna expression in developing embryo. Department of Chemical and Radiation Nur Duale

Glycan and Monosaccharide Workshop Eoin Cosgrave David Wayland Bill Warren

Human Genome Project (HGP) An international research effort to sequence and map all of the genes of Homo sapiens (the human genome) Completed p in Apr

Extended Mass Range Triple Quadrupole for Routine Analysis of High Mass-to-charge Peptide Ions

Hao D. H., Ma W. G., Sheng Y. L., Zhang J. B., Jin Y. F., Yang H. Q., Li Z. G., Wang S. S., GONG Ming*

Supporting Information MALDI versus ESI the impact of the ion source on peptide identification

Identifying Thyroid Carcinoma Subtypes and Outcomes through Gene Expression Data Kun-Hsing Yu, Wei Wang, Chung-Yu Wang

Improve Protein Analysis with the New, Mass Spectrometry- Compatible ProteasMAX Surfactant

Proteomics of body liquids as a source for potential methods for medical diagnostics Prof. Dr. Evgeny Nikolaev

Introduction to Discrimination in Microarray Data Analysis

IPA Advanced Training Course

Extracellular Vesicle RNA isolation Kits

Automated Sample Preparation/Concentration of Biological Samples Prior to Analysis via MALDI-TOF Mass Spectroscopy Application Note 222

Tissue and Fluid Proteomics Chao-Cheng (Sam) Wang

Pinpoint Slide RNA Isolation System II Catalog No. R1007

Learning Objectives. Overview of topics to be discussed 10/25/2013 HIGH RESOLUTION MASS SPECTROMETRY (HRMS) IN DISCOVERY PROTEOMICS

MS1 and MS2 crosstalk in label free quantitation of mass spectrometry data independent acquisitions

Measurement is the process of observing and recording the observations. Two important issues:

Problem Set 5, 7.06, Spring of 13

RNA preparation from extracted paraffin cores:

Transcription:

Suppression of the Malignant Phenotype of Bladder Cancer Cells Investigations of the Proteome in Relation to Phenotype and Gene Expression

Topics Modulation of Phenotype by Extracellular Matrix. Bioinformatics techniques for identifying significant genes and proteins. Integration of Transcriptomic and Proteomic levels of information concerning phenotype.

Cancer Is A Tissue Level Disease 6 1 Genetically Initiated Cell 5 Phenotypically Altered Field Cells 3 3 2 Stromal Cell 1. Paracrine interactions from initiated cell. 2. Paracrine interactions through stromal cells. 3. Juxtacrine interactions with neighboring cells. 4. Matrix-mediated interactions (normal or altered). 5. Epigenetic promotion of initiated cell. 6. Epigenetic suppression of malignant phenotype. 2 4

Cancer Cells and Extracellular Matrix (ECM) An established tumor modulates the ECM. Evolving tumors and metastases are exposed to NORMAL matrix. Normal matrix may be suppressive. Progression requires escape from tissue level controls modulated by matrix. Most cancer research is done with cells grown on plastic. Tissue level controls are not active.

Model System for Effect of ECM Matrigel: EHS tumor ECM. Representative of matrix remodeled by cancer. SISgel: Gel made by pepsin treatment of Small Intestinal Submucosa. Representative of normal matrix. Plastic: Eliminates most matrix-dependent features of growth and differentiation.

Bladder Cancer 56,000 new cases, 12,500 deaths in US. 2 pathways Papillary (85%) limited invasive or metastatic potential. 15% progress. Flat (15%) develop from CIS. Highly invasive with poor prognosis. What are the functional genomics and proteomics of these phenotypes and can markers or targets be identified?

TCCSUP High Grade Human Invasive J82 High Grade Human Invasive JB-V- Metastatic/Invasive variant of JP253. JP253 Human Low Grade, slight invasion RT4-Human Papilloma HUC- Immortalized normal Human Urothelial Cells

Does this Represent Real Biology?

Growth of J82 bladder cancer cell xenografts. Tumor Growth at Indicated Time Substrate Coinjection 7 Days 21 Days Plastic Matrigel + ++ Plastic SISgel 0 ++ SISgel Matrigel 0 + SISgel SISgel 0 0 Matrigel Matrigel + ++ Matrigel SISgel 0 0

The ECM can suppress the malignant phenotype What we see in culture represents real biological differences in the phenotype. The malignant phenotype can be suppressed by normal matrix. Understanding the mechanism might identify targets for therapy or biomarkers with which to stratify disease or risk.

The Genomic/Proteomic Approach Can we identify mechanisms that produce the malignant phenotype? Can we identify genes or proteins of mechanistic interest with a low false positive chance? Do we have bioinformatic techniques that allow us to assemble a system-level description of the mechanism that integrates genomics and proteomics?

Transcriptome Analysis 1186 cancer-related related genes on nylon. Filter out genes not expressed 3 sd above background. Leaves 311 expressed genes, all well annotated. More recently, 22,465 genes in genome-wide scan.

Expression Ratio of 311 Expressed Genes by Cell Type, Matrigel vs. SISgel 100000 10000 1000 M/S Expression Ratio 100 10 1 0.1 0.01 0.001 0.0001 0.00001 1 11 21 31 41 51 61 71 81 91 101 111 121 131 141 151 161 171 181 191 201 211 221 231 241 251 261 271 281 291 301 311 Gene Number HUC RT4 JP253 JBV J82 TCCSUP

Expression Ratio of Genes in J82 Cells 1000 100 10 M/S 1 0.1 0 50 100 150 200 250 300 0.01 0.001 Gene Number

Complexity and Simplicity Pairwise comparisons often add complexity to an already complex situation. Not really the answer to the questions we asked. The simplicity this side of complexity is worth nothing. The simplicity on the other side of complexity is worth everything. Oliver Wendell Holmes.

Supervised vs Unsupervised Analysis Unsupervised: Let the data talk to me. Finding relationships among data points. Biology is not inherent in such analysis. Requires replicates for statistical power. Supervised: : Data is referred to external identifiers that encapsulate biological relationships among experiments. Linkages increases power by raising a pattern above the noise. noise.

IFITM1 (Found by Statistical Analysis) 1 0.9 0.8 1400 0.7 1200 0.6 1000 0.5 800 0.4 600 0.3 400 200 0.2 0.1 0 0 HUC RT4 JP JB J82 SUP 3-D Column 1 3-D Plastic SIS Column 2 3-D Column Matrigel 3 SIS Plastic Matrigel Interferon inducible protein 9-27 (IFITM1) is a signaling component up-regulated in 3-D growth. Proposed protein-level functionality of IFITM1 deduced from literature and expression patterns.

Expr. Of Malignancy Initial "Template Model" for Systems Study of Transcriptome and Proteome 8 7 6 5 4 3 2 1 0 Expressed Malignancy Matrigel (+) SISgel plastic HUC RT4 JP253 JB-V J82 TCCSUP Inherent Malignancy

Final Fit of "Template Model" for Systems Study of Transcriptome and Proteome 10 8 6 4 2 Expressed Malignancy Expr. Of Malignancy 0 Matrigel (+) SISgel Plastic HUC RT4 JP253 JB-V J82 TCCSUP Inherent Malignancy

Genes Matching Template Number of genes with correlations exceeding the value in the first column as a function of model. Correlation coefficient # Genes Matching Model Complete Data Set # Genes Matching Model TCCSUP Excluded # Genes Matching Model Randomized Data > 0.4 53 86 12 > 0.5 17 63 3 > 0.6 1 47 0 > 0.7 0 17 0 > 0.8 0 1 0

Discriminant Function Analysis 15 genes distinguish the matrix on which the cells are growing. 14 genes identify the inherent malignancy of bladder cancer cells grown in 3-dimensional culture.

DFA with 8 genes distinguishes the growth substrate 4 3 2 Root 2 1 0-1 -2-3 -4-15 -10-5 0 5 10 15 Root 1 Plastic SISgel Matrigel

Pathway Construction C10orf7 + S-Phase XRCC1 - PARP2 EGF + - + PARP1 + EGR1 + TP53 + CCNB1 + Apoptosis

The Proteome Is not a direct connection to the transcriptome (i.e. mrna and protein are not equivalent.) Like the transcriptome, is dynamic and ever changing. It is not an entity in the sense the genome is. Post-translational translational modification Degradation Protein-protein interaction Splice variants RNA-level control of gene expression and translation

2-D D Gels of TCCSUP on Gels SISGel Matrigel

Personal Philosophy on New Methods A method grows beyond instrument development when real biology can be done fairly simply. That time is now for proteomics. It is important to avoid false positives.

2-D D Chromatography Automated system with 1 injection. First dimension is pi a a fundamental physical property that can be independently measured. Second dimension is hydrophobicity a fundamental physical property that can be standardized. Fractions are collected free of gel for MS identification.

1 st Dimension: J82 on Plastic (Full) UV-1 JA82_Matrigel_101803 ph Monitor JA82_Matrigel_101803 9.0 0.25 8.5 8.0 0.20 7.5 0.15 7.0 6.5 AU 0.10 6.0 ph 0.05 5.5 5.0 0.00 4.5 4.0-0.05 3.5 0 20 40 60 80 100 120 140 160 180 200 Minutes

1 st Dimension: J82 cells Plastic vs SISgel 0.16 9.0 0.14 8.5 0.12 8.0 7.5 0.10 AU 0.08 0.06 Plastic SISgel 7.0 6.5 6.0 ph 0.04 5.5 0.02 5.0 0.00 4.5 4.0-0.02 3.5 60 65 70 75 80 85 90 95 100 105 110 115 120 125 130 135 140 Minutes

1 st Dimension SISgel vs. Matrigel vs. Plastic 0.16 9.0 0.14 0.12 0.10 0.08 Plastic Matrigel SISgel 8.5 8.0 7.5 7.0 6.5 AU 0.06 6.0 ph 0.04 5.5 0.02 5.0 0.00 4.5 4.0-0.02 3.5 60 65 70 75 80 85 90 95 100 105 110 115 120 125 130 135 140 Minutes

1st Dimension Summary Major differences among first dimension separations. More protein eluted during ph gradient from cells grown on gels than on plastic. (confirms transcriptome findings) Proteomes of cells grown on SISgel and Matrigel show major qualitative and quantitative differences.

Components Identified in 2 nd Dimension Separations of 1.5 mg protein J82 cells grown on SISgel: 1984 J82 cells grown on Matrigel: 1582 J82 cells grown on Plastic: 1345

DeltaVue plastic vs Matrigel Overlay Plastic Difference Matrigel Matrigel

DeltaVue plastic vs Matrigel Overlay lane 15, Zoom to 13-22 min all lanes Overlay Difference Matrigel

DeltaVue plastic vs Matrigel Overlay lane 14, Zoom to 13-22 min all lanes Overlay Difference Matrigel

DeltaVue SISgel vs Matrigel Overlay lane 14, Zoom to 13-22 min all lanes Overlay Difference Matrigel

DeltaVue plastic vs Matrigel Overlay lane 9, Zoom to 13-22 min lanes 2-122 Overlay Difference Matrigel

DeltaVue plastic vs Matrigel Overlay lane 7, Zoom to 13-22 min lanes 2-122 Overlay Difference Matrigel

Proteomes of J82 Cells on Matrigel and SISgel Matrigel SISgel

MS Identification of Proteins 28 components identified with major differences in expression. Lyophilization and trypsin digestion at ~30:1 molar ratio (estimated from UV absorbance). Zip-tip clean-up. MALDI-TOF and MS-MS for identification. Indications some fractions contain >1 proteins.

MS Analysis of Fractions 040422ms2(2047) cid 230 MF33 F6+F70002, 040422ms2(1919.1) cid 230 MF33 F6+F70002 Kratos PCAxima QIT V2.3.4 %Int. 4.7 mv 8.0 mv 100 80 60 40 20 0 681.2 682.2 480.0 921.6 681.2 1479.9 523.0 600.1 956.6 1092.7 1908.2 1910.3 1874.3 2031.4 1391.9 1667.1 2033.3 ER60 (protein disulfide isomerase) HSP60 400 600 800 1000 1200 1400 1600 1800 2000 2200 2400 26002[c].E Mass/Charge 3[c].E

Proteome vs Transcriptome Chaperones and protein-processing processing proteins have been identified tentatively as overrepresented in 13 tentative identifications. So far, based on 13 tentative protein identifications, the proteins identified as being differentially expressed show only modest correlation with the RNAs shown to be differentially expressed.

The Next Steps Build a database of components by pi-hydrophobocity and identify interesting components by techniques used in microarray studies as biology is varied systematically. Characterize the two gels. Attempt to identify pathways rather than individual proteins. Major emphasis to abundant proteins. Glycosylation a a major question. Integrate with transcriptome data to build dynamic picture of regulation of phenotype.

Integration of Transcriptome and Proteome The answer lies not in statistics but in cell biology. Discovery or hypothesis-generating phase. Hypothesis-testing testing phase.

Summary There are major differences among the same J82 cells grown on Matrigel, SISgel and plastic. Proteome is not simply a reflection of transcriptome It is not important to identify all proteins, but rather to identify with confidence differences related to mechanism. The Beckman 2-D 2 D chromatographic system for proteomics is reproducible and yields a picture of the proteome that captures its complexity.

Thanks to: My lab group: Kim Kyker Jean Coffman Norma McElwee Bioinformatics group (OMRF) Mike Centola Igor Dozmorov Nick Knowlton Beckman Coulter Mike Simonian, Edna Betgovarez MS Group Hiro Matsumoto Nobu Takemori